Preoperative and postoperative evaluation of thyroid disease in patients undergoing surgical treatment of primary hyperparathyroidism

Endocrine Practice

Volumn 16, Issue 1, 2010, Pages 7-13

  Gul, Kamile ^a   Ozdemir, Didem ^a   Korukluoglu, Birol ^a   Ersoy, Pamir Eren ^a   Aydin, Raci ^a   Ugras, Serdar Nevzat ^b   Ersoy, Reyhan ^a   Cakir, Bekir ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTITHYROID AGENT; CALCIUM; LEVOTHYROXINE; PARATHYROID HORMONE; PHOSPHORUS; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CONCENTRATION (PARAMETERS); CYTOLOGY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; HYPOTHYROIDISM; LABORATORY; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; NODULAR HYPERPLASIA; PAPILLARY THYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID DISEASE; THYROIDITIS; TOXIC GOITER;

ADULT; AGED; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID DISEASES;

EID: 77649166020     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09138.OR     Document Type: Article

References (26)

1. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11:49-54.
2. Kissin M, Bakst H. Coexisting myxedema and hyperparathyroidism. J Clin Endocrinol Metab. 1947;7:152-156.
3. Zheng YX, Xu SM, Wang P, Chen L. Preoperative localization and minimally invasive management of primary hyperparathyroidism concomitant with thyroid disease. J Zhejiang Univ Sci B. 2007;8:626-631.
4. Sidhu S, Campbell P. Thyroid pathology associated with primary hyperparathyroidism. Aust N Z J Surg. 2000;70:285-287.
5. Bentrem DJ, Angelos P, Talamonti MS, Nayar R. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid. 2002;12:1109-1112.
6. Kösem M, Algün E, Kotan C, Harman M, Oztürk M. Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: Controversies about minimal invasive parathyroid surgery. Acta Chir Belg. 2004;104:568-571.
7. Ogawa T, Kammori M, Tsuji E, et al. Preoperative evaluation of thyroid pathology in patients with primary hyperparathyroidism. Thyroid. 2007;17:59-62.
8. Morita SY, Somervell H, Umbricht CB, Dackiw AP, Zeiger MA. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery. 2008;144:862-866.
9. Masatsugu T, Yamashita H, Noguchi S, et al. Thyroid evaluation in patients with primary hyperparathyroidism. Endoc J. 2005;52:177-182.
10. Milas M, Mensah A, Alghoul M, et al. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid. 2005;15:1055-1059.
11. Klemm T, Lamesch P, Paschke R. Coincidence of hot thyroid nodules and primary hyperparathyroidism. Exp Clin Endocrinol Diabetes. 1999;107:295-298.
12. Loviselli A, Sammartano L, Mastinu GL, et al. Parathyroid carcinoma and primary autoimmune hypothyroidism in an elderly woman. J Endocrinol Invest. 1997;20:82-85.
13. Erdoǧan G, Erdogan MF, Emral R, et al. Iodine status and goiter prevalence in Turkey before mandatory iodization. J Endocrinol Invest. 2002;25:224-228.
14. Delange F, Lecomte P. Iodine supplementation: Benefits outweigh risks. Drug Saf. 2000;22:89-95.
15. Lupoli GA, Fonderico F, Colarusso S, et al. Current management of differentiated thyroid carcinoma. Med Sci Monit. 2005;11:368-373.
16. Wagner B, Begic-Karup S, Raber W, Schneider B, Waldhäusl W, Vierhapper H. Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium. Exp Clin Endocrinol Diabetes. 1999;107:457-461.
17. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: Impact on presentation, management, and outcome. Surgery. 1999;126:1070-1076.
18. Krause UC, Friedrich JH, Olbricht T, Metz K. Association of primary hyperparathyroidism and non-medullary thyroid cancer. Eur J Surg. 1996;162:685-689.
19. Fedorak IJ, Salti G, Fulton N, Schark C, Straus FH 2nd, Kaplan EL. Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: A continuing dilemma. Am Surg. 1994;60:427-431.
20. van der Schaar H, Mulder H. Lesions of the thyroid gland in patients with primary hyperparathyroidism. Surg Gynecol Obstet. 1985;160:407-408.
21. Eigelberger MS, Clark OH. Surgical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am. 2000;29:479-502.
22. Prager G, Czerny C, Ofluoglu S, et al. Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg. 2003;196:541-548.
23. Regal M, Páramo C, Luna Cano R, et al. Coexistence of primary hyperparathyroidism and thyroid disease. J Endocrinol Invest. 1999;22:191-197.
24. Burguera B, Gharib H. Thyroid incidentalomas. Prevalance, diagnosis, significance, and management. Endocrinol Metab Clin North Am. 2000;29:187-203.
25. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol. 1988;90:72-76.
26. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systemic autopsy study. Cancer. 1985;56:531-538.